“When we own portions of outstanding businesses with outstanding managements, our favorite holding period is forever.”
— Warren Buffett
The investment philosophy practiced by Warren Buffett calls for investors to take a long-term horizon when making an investment, such as a two-decade holding period (or even longer), and reconsider making the investment in the first place if unable to envision holding the stock for at least five years. Today, we look at how such a long-term strategy would have done for investors in Gilead Sciences Inc (NASD: GILD) back in 2000, holding through to today.
|Average annual return:||17.97%|
As shown above, the two-decade investment result worked out exceptionally well, with an annualized rate of return of 17.97%. This would have turned a $10K investment made 20 years ago into $273,034.88 today (as of 10/26/2020). On a total return basis, that’s a result of 2,631.91% (something to think about: how might GILD shares perform over the next 20 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
Beyond share price change, another component of GILD’s total return these past 20 years has been the payment by Gilead Sciences Inc of $12.05/share in dividends to shareholders. Automatic reinvestment of dividends can be a wonderful way to compound returns, and for the above calculations we presume that dividends are reinvested into additional shares of stock. (For the purpose of these calcuations, the closing price on ex-date is used).
Based upon the most recent annualized dividend rate of 2.72/share, we calculate that GILD has a current yield of approximately 4.54%. Another interesting datapoint we can examine is ‘yield on cost’ — in other words, we can express the current annualized dividend of 2.72 against the original $2.58/share purchase price. This works out to a yield on cost of 175.97%.
More investment wisdom to ponder:
“Investors should always keep in mind that the most important metric is not the returns achieved but the returns weighed against the risks incurred. Ultimately, nothing should be more important to investors than the ability to sleep soundly at night.” — Seth Klarman